Micro Cap Growth Fund
Daily price w/o sales charge as of 04/17/2025
$14.00
$0.06
YTD Returns w/o sales charge as of 04/17/2025
-20.45%
Please click here for performance current to the most recent quarter-end and month-end.
Summary
Summary
Fund Basicsas of 03/31/2025
- Total Net Assets
- $160.90 M
- Inception Date
- 05/01/2000
- Dividend Frequency
- Annually
- Fund Gross Expense Ratio
- 1.38%
- Fund Net Expense Ratio
- 1.38%
- Number of Holdings
- 73
- Minimum Initial Investment
- $1,500+
Fund Expense Ratio :
Gross 1.38%
Net 1.38%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | -17.90% | -3.22% | -1.95% | 13.85% | 9.46% | 9.30% |
| Lipper Category Avg. Small-Cap Growth Funds | -10.55% | -5.61% | -0.42% | 11.22% | 7.24% | - |
| Russell Microcap® Growth Index | -17.75% | -5.93% | -3.79% | 8.16% | 2.70% | - |
| w/ sales charge | -22.60% | -8.78% | -3.88% | 12.52% | 8.81% | 9.04% |
Fund Expense Ratio :
Gross 1.38%
Net 1.38%
Fund Expense Ratio :
Gross 1.38%
Net 1.38%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | -17.90% | -3.22% | -1.95% | 13.85% | 9.46% | 9.30% |
| Lipper Category Avg. Small-Cap Growth Funds | -10.55% | -5.61% | -0.42% | 11.22% | 7.24% | - |
| Russell Microcap® Growth Index | -17.75% | -5.93% | -3.79% | 8.16% | 2.70% | - |
| w/ sales charge | -22.60% | -8.78% | -3.88% | 12.52% | 8.81% | 9.04% |
Fund Expense Ratio :
Gross 1.38%
Net 1.38%
Returns with sales charges reflect a maximum sales charge of 5.75%.
Past performance is not a reliable indicator or guarantee of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost.
TEN LARGEST HOLDINGS as of 03/31/2025View Portfolio
| Holding | Assets |
|---|---|
| Tarsus Pharmaceuticals Inc | 4.0% |
| Universal Technical Institute Inc | 3.3% |
| Natural Grocers by Vitamin Cottage Inc | 2.8% |
| Chefs' Warehouse Inc/The | 2.7% |
| Grindr Inc | 2.6% |
| CRA International Inc | 2.5% |
| OSI Systems Inc | 2.5% |
| Mirum Pharmaceuticals Inc | 2.4% |
| Grid Dynamics Holdings Inc | 2.4% |
| Scholar Rock Holding Corp | 2.2% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 03/31/2025View Portfolio
| Sector | Weighting |
|---|
| Sector | Weighting |
|---|---|
| Communication Services | |
| Real Estate | |
| Utilities | |
| Consumer Discretionary | |
| Consumer Staples | |
| Energy | |
| Financials | |
| Health Care | |
| Industrials | |
| Information Technology | |
| Materials |
INVESTMENT TEAM
Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
Fund Expense Ratio :
Gross 1.38%
Net 1.38%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | -17.90% | -3.22% | -1.95% | 13.85% | 9.46% | 9.30% |
| Lipper Category Avg. Small-Cap Growth Funds | -10.55% | -5.61% | -0.42% | 11.22% | 7.24% | - |
| Russell Microcap® Growth Index | -17.75% | -5.93% | -3.79% | 8.16% | 2.70% | - |
| w/ sales charge | -22.60% | -8.78% | -3.88% | 12.52% | 8.81% | 9.04% |
Fund Expense Ratio :
Gross 1.38%
Net 1.38%
Fund Expense Ratio :
Gross 1.38%
Net 1.38%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | -17.90% | -3.22% | -1.95% | 13.85% | 9.46% | 9.30% |
| Lipper Category Avg. Small-Cap Growth Funds | -10.55% | -5.61% | -0.42% | 11.22% | 7.24% | - |
| Russell Microcap® Growth Index | -17.75% | -5.93% | -3.79% | 8.16% | 2.70% | - |
| w/ sales charge | -22.60% | -8.78% | -3.88% | 12.52% | 8.81% | 9.04% |
Fund Expense Ratio :
Gross 1.38%
Net 1.38%
Returns with sales charges reflect a maximum sales charge of 5.75%.
Past performance is not a reliable indicator or guarantee of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost.
| Year | Fund Returns | Russell Microcap® Growth Index |
|---|
| 2024 | 26.89% | 21.91% |
| 2023 | 5.88% | 9.11% |
| 2022 | -29.27% | -29.76% |
| 2021 | 3.46% | 0.88% |
| 2020 | 79.42% | 40.13% |
| 2019 | 34.57% | 23.33% |
| 2018 | 2.74% | -14.18% |
| 2017 | 38.43% | 16.65% |
| 2016 | 2.07% | 6.86% |
| 2015 | -6.38% | -3.85% |
| 2014 | 10.83% | - |
| 2013 | 78.53% | - |
| 2012 | 2.35% | - |
| 2011 | -5.87% | - |
| 2010 | 33.77% | - |
| 2009 | 52.61% | - |
| 2008 | -46.45% | - |
| 2007 | 22.76% | - |
| 2006 | 25.37% | - |
| 2005 | 2.55% | - |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|
| 2025 | -17.90% | - | - | - |
| 2024 | 7.64% | 0.07% | 6.89% | 10.21% |
| 2023 | 5.50% | 4.20% | -13.40% | 11.23% |
| 2022 | -17.22% | -22.57% | 8.17% | 2.02% |
| 2021 | 12.29% | -0.15% | -9.42% | 1.87% |
| 2020 | -24.28% | 47.61% | 17.48% | 36.65% |
| 2019 | 22.67% | 7.47% | -13.91% | 18.57% |
| 2018 | 5.24% | 15.77% | 10.08% | -23.39% |
| 2017 | 9.00% | 8.12% | 13.61% | 3.39% |
| 2016 | -13.70% | 6.01% | 14.49% | -2.55% |
| 2015 | 7.33% | 4.15% | -16.30% | 0.06% |
| 2014 | 7.92% | -6.53% | -6.55% | 17.58% |
| 2013 | 21.83% | 15.00% | 17.29% | 8.65% |
| 2012 | 17.67% | -9.76% | 1.32% | -4.87% |
| 2011 | 4.82% | 0.11% | -21.90% | 14.86% |
| 2010 | 6.60% | -8.74% | 15.08% | 19.49% |
| 2009 | -0.95% | 31.46% | 13.47% | 3.29% |
| 2008 | -23.22% | 4.46% | -5.93% | -29.02% |
| 2007 | 5.64% | 9.81% | 4.01% | 1.76% |
| 2006 | 17.15% | -9.83% | 1.22% | 17.25% |
| 2005 | -9.50% | 5.88% | 6.91% | 0.10% |
| 2004 | 12.33% | 1.65% | -11.11% | 24.03% |
| 2003 | -3.55% | 27.29% | 11.68% | 8.93% |
| 2002 | -0.18% | -12.74% | -21.79% | 1.33% |
| 2001 | 2.34% | 12.03% | -21.11% | 29.32% |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
Growth of $10,000 as of 03/31/2025
The chart begins on the Fund's inception date of 05/01/2000.
Based on a hypothetical Class A share investment of $10,000 on 05/01/2000 without sales charge and includes the reinvestment of all distributions.
NAV Historical Prices
| Date | Net Asset Value |
|---|
Portfolio
Portfolio
| Holding | Sector | Assets |
|---|
| Tarsus Pharmaceuticals Inc | Health Care | 4.0% |
| Universal Technical Institute Inc | Consumer Discretionary | 3.3% |
| Natural Grocers by Vitamin Cottage Inc | Consumer Staples | 2.8% |
| Chefs' Warehouse Inc/The | Consumer Staples | 2.7% |
| Grindr Inc | Communication Services | 2.6% |
| CRA International Inc | Industrials | 2.5% |
| OSI Systems Inc | Information Technology | 2.5% |
| Mirum Pharmaceuticals Inc | Health Care | 2.4% |
| Grid Dynamics Holdings Inc | Information Technology | 2.4% |
| Scholar Rock Holding Corp | Health Care | 2.2% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
| Holding | Sector | Assets |
|---|
| Universal Technical Institute Inc | Consumer Discretionary | 3.2% |
| Tarsus Pharmaceuticals Inc | Health Care | 3.1% |
| GeneDx Holdings Corp | Health Care | 2.9% |
| Chefs' Warehouse Inc/The | Consumer Staples | 2.7% |
| OSI Systems Inc | Information Technology | 2.6% |
| Scholar Rock Holding Corp | Health Care | 2.4% |
| Natural Grocers by Vitamin Cottage Inc | Consumer Staples | 2.3% |
| Grindr Inc | Communication Services | 2.3% |
| Alkami Technology Inc | Information Technology | 2.3% |
| Mirum Pharmaceuticals Inc | Health Care | 2.2% |
| Stride Inc | Consumer Discretionary | 2.1% |
| Grid Dynamics Holdings Inc | Information Technology | 2.1% |
| Paymentus Holdings Inc | Financials | 2.0% |
| CRA International Inc | Industrials | 2.0% |
| Vital Farms Inc | Consumer Staples | 1.9% |
| Weave Communications Inc | Information Technology | 1.8% |
| Life360 Inc | Information Technology | 1.8% |
| Vita Coco Co Inc/The | Consumer Staples | 1.7% |
| Payoneer Global Inc | Financials | 1.6% |
| Powerfleet Inc NJ | Information Technology | 1.6% |
| Argan Inc | Industrials | 1.6% |
| Xometry Inc | Industrials | 1.5% |
| Piper Sandler Cos | Financials | 1.5% |
| IMAX Corp | Communication Services | 1.5% |
| Cellebrite DI Ltd | Information Technology | 1.5% |
| Willdan Group Inc | Industrials | 1.4% |
| CareDx Inc | Health Care | 1.4% |
| Veracyte Inc | Health Care | 1.4% |
| Kratos Defense & Security Solutions Inc | Industrials | 1.4% |
| PAR Technology Corp | Information Technology | 1.4% |
| Primoris Services Corp | Industrials | 1.4% |
| Ambarella Inc | Information Technology | 1.3% |
| PROCEPT BioRobotics Corp | Health Care | 1.3% |
| UFP Technologies Inc | Health Care | 1.3% |
| Artivion Inc | Health Care | 1.3% |
| VSE Corp | Industrials | 1.3% |
| Travere Therapeutics Inc | Health Care | 1.2% |
| Opera Ltd | Information Technology | 1.2% |
| Oddity Tech Ltd | Consumer Staples | 1.2% |
| Warby Parker Inc | Consumer Discretionary | 1.1% |
| Core Scientific Inc | Information Technology | 1.1% |
| Centessa Pharmaceuticals PLC | Health Care | 1.1% |
| Arcellx Inc | Health Care | 1.1% |
| Adaptive Biotechnologies Corp | Health Care | 1.1% |
| OneSpaWorld Holdings Ltd | Consumer Discretionary | 1.0% |
| Evolus Inc | Health Care | 0.9% |
| QuinStreet Inc | Communication Services | 0.9% |
| Rhythm Pharmaceuticals Inc | Health Care | 0.9% |
| Ceribell Inc | Health Care | 0.9% |
| Janux Therapeutics Inc | Health Care | 0.9% |
| Credo Technology Group Holding Ltd | Information Technology | 0.9% |
| 89bio Inc | Health Care | 0.8% |
| Marex Group PLC | Financials | 0.8% |
| uniQure NV | Health Care | 0.8% |
| Powell Industries Inc | Industrials | 0.8% |
| Phreesia Inc | Health Care | 0.8% |
| Zeta Global Holdings Corp | Information Technology | 0.8% |
| Viant Technology Inc | Information Technology | 0.8% |
| NeuroPace Inc | Health Care | 0.7% |
| Vericel Corp | Health Care | 0.7% |
| Sweetgreen Inc | Consumer Discretionary | 0.7% |
| Xenon Pharmaceuticals Inc | Health Care | 0.7% |
| CVRx Inc | Health Care | 0.6% |
| Butterfly Network Inc | Health Care | 0.6% |
| Vera Therapeutics Inc | Health Care | 0.5% |
| Intuitive Machines Inc | Industrials | 0.5% |
| Agilysys Inc | Information Technology | 0.5% |
| Enliven Therapeutics Inc | Health Care | 0.5% |
| Sterling Infrastructure Inc | Industrials | 0.5% |
| Nurix Therapeutics Inc | Health Care | 0.5% |
| Viridian Therapeutics Inc | Health Care | 0.5% |
| Twist Bioscience Corp | Health Care | 0.5% |
| Xponential Fitness Inc | Consumer Discretionary | 0.4% |
| Beta Bionics Inc | Health Care | 0.3% |
| Karman Holdings Inc | Industrials | 0.0% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 03/31/2025
| Sector | Weighting | Fund Change from Previous Quarter |
|---|
| Sector | Weighting | Fund Change from Previous Quarter |
|---|---|---|
| Communication Services |
2.2%
|
|
| Real Estate | 0.0% | |
| Utilities | 0.0% | |
| Consumer Discretionary |
 0.9%
|
|
| Consumer Staples |
1.3%
|
|
| Energy | 0.0% | |
| Financials |
0.8%
|
|
| Health Care | 0.0% | |
| Industrials |
0.5%
|
|
| Information Technology |
3.7%
|
|
| Materials | 0.0% |
Portfolio Details as of 03/31/2025
- Total Net Assets
- $160.90 M
- Number of Holdings
- 73
- Weighted Average Market Cap.
- 2.2 B
- P/B Ratio
- 4.9x
- P/E Ratio
- 28.6x
To view definitions for the above Portfolio Details, Click here.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
Dividends & Cap Gains
Dividends & Cap Gains
Dividend Payments
- YTD Dividends Paidas of 04/17/2025
- $0
- Dividend Frequency
- Annually
| Record Date | Ex-Dividend Date | Reinvest & Payable Date | Dividend | Reinvest Price |
|---|---|---|---|---|
| 11/20/2001 | 11/21/2001 | 11/21/2001 | $0.00740 | $10.09 |
Upcoming Dividend Payment Dates
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date | Reinvest & Payable Date |
|---|---|---|
| 12/01/2025 | 12/02/2025 | 12/02/2025 |
Capital Gains Distributions
| Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
|---|---|---|---|---|---|
| 11/23/2020 | 11/24/2020 | $2.8043 | $2.2741 | $5.0784 | $15.43 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Fees & Expenses
Fees & Expenses
Sales Charge Schedule as of 04/17/2025
| Sales Charge | Dealer's Concession | Prices at Breakpoint | |
|---|---|---|---|
| Less than $50,000 | 5.75% | 5.00% | $14.85 |
| $50,000 to $99,999 | 4.75% | 4.00% | $14.70 |
| $100,000 to $249,999 | 3.95% | 3.25% | $14.58 |
| $250,000 to $499,999 | 2.75% | 2.25% | $14.40 |
| $500,000 to $999,999 | 1.95% | 1.75% | $14.28 |
| $1,000,000 to $5,000,000 | 0.00% | 1.00% | $14.00 |
The 12b-1 trail commission is 0.15% (accrues immediately) for all fixed-income and municipal income funds.
Class A shares purchased without a sales charge (commissionable NAV) will be subject to a CDSC of 1% if they are redeemed before the first day of the month in which the one-year anniversary of the purchase falls.
Expense Ratioas of 03/31/2025
| Fund Gross Expense Ratio | 1.38% |
| Fund Net Expense Ratio | 1.38% |
Fund Documents
Fund Documents
|
0Documents selected
|
||||
|---|---|---|---|---|
|
Portfolio Holdings 1Q
Publish Date:11/03/2015
|
||||
|
Portfolio Holdings 3Q
Publish Date:11/03/2015
|
||||
|
Summary Prospectus
Publish Date:11/03/2015
|
||||
|
Statutory Prospectus
Publish Date:11/03/2015
|
||||
|
SAI
Publish Date:11/03/2015
|
||||
|
Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
|
Annual Tailored Shareholder Report
Publish Date:11/03/2015
|
||||
|
Semi-Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
|
Fact Sheet
Publish Date:11/03/2015
|